Ask AI
ProCE Banner Events

Share

XDROs in Complex Clinical Infections: An Advanced Course on the Hardest-to-Treat Cases

Learn about infections caused by Gram-negative extensively drug-resistant organisms (XDROs) including molecular epidemiology associated with antimicrobial resistance and approaches to selecting treatment regimens based on the latest data, patient-specific factors and pharmacokinetic/pharmacodynamic considerations through challenging clinical cases led by expert faculty.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 1.00 Nursing contact hour

This event has expired. No longer available for credits.

Who Should Attend

NPs, PAs and Physicians

Time and location

Monday, February 06, 2023

6:30 PM - 7:30 PM Eastern Time (ET)

In-personVirtual

Morton's The Steakhouse North Miami Beach
17399 Biscayne Blvd
Miami, Florida 33160

Boardroom A

Agenda

  • About extensively drug-resistant organisms (XDROs)
  • Interactive patient cases of infections caused by:
    • Carbapenem-resistant Acinetobacter baumannii
    • Pseudomonas aeruginosa with difficult-to-treat resistance
    • Metallo-β-lactamase–producing Enterobacterales


*Please note, this meeting will be held in person with no live simulcast available.

Location

Venue Name

Morton's The Steakhouse North Miami Beach

Address

Morton's The Steakhouse North Miami Beach
17399 Biscayne Blvd
Miami, Florida 33160

Room Name

Boardroom A

CME/CE Info

Goal Statement
The goal of this activity is to improve participants’ competence in selecting appropriate antibiotic regimens for empiric or targeted treatment of complex clinical infections caused by antimicrobial resistant gram-negative pathogens.

Target Audience
This program is intended for physicians (eg, critical care/pulmonologist, infectious disease, internal medicine/hospitalist), pharmacists (critical care, infectious disease), nurses, and other healthcare professionals (eg, NPs/PAs, microbiologists) who provide care for patients with antimicrobial resistant gram-negative infections.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Dfferentiate clinically relevant extensively drug resistant gram-negative organisms (XDROs) including epidemiology, mechanisms of antimicrobial resistance, and virulence factors
  • Compare novel antimicrobial treatment options for patients with antimicrobial resistant gram-negative infections including pharmacokinetics/pharmacodynamics and activity in the setting of key resistance mechanisms
  • Apply latest data and suggested approaches for selection of optimized treatment regimens targeting XDROs in patients with complex clinical infections

Accreditation

 

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education
CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008176-0000-22-250-L01-P

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Supported by an educational grant from Shionogi Inc.

Contact Information

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Additional Information

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact meetings@clinicaloptions.com prior to the live event.